Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114674456 | 11467445 | 6 | F | 20130718 | 20160111 | 20150908 | 20160729 | EXP | PHHY2014FR132767 | NOVARTIS | 49.70 | YR | M | Y | 75.00000 | KG | 20160730 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114674456 | 11467445 | 1 | PS | CERTICAN | EVEROLIMUS | 1 | Oral | 4 MG, QD | 363.931 | MG | U | 21560 | 4 | MG | QD | ||||
| 114674456 | 11467445 | 2 | SS | CERTICAN | EVEROLIMUS | 1 | Oral | 2 MG, QD | 363.931 | MG | U | 21560 | 2 | MG | QD | ||||
| 114674456 | 11467445 | 3 | SS | CERTICAN | EVEROLIMUS | 1 | Oral | 1.5 MG, QD | 363.931 | MG | U | 21560 | 1.5 | MG | QD | ||||
| 114674456 | 11467445 | 4 | SS | CERTICAN | EVEROLIMUS | 1 | Oral | 1 MG, QD | 363.931 | MG | U | 21560 | 1 | MG | QD | ||||
| 114674456 | 11467445 | 5 | SS | CERTICAN | EVEROLIMUS | 1 | Oral | 1.5 MG, QD | 363.931 | MG | U | 21560 | 1.5 | MG | QD | ||||
| 114674456 | 11467445 | 6 | SS | CERTICAN | EVEROLIMUS | 1 | Oral | 2 MG, QD | 363.931 | MG | U | 21560 | 2 | MG | QD | ||||
| 114674456 | 11467445 | 7 | SS | CERTICAN | EVEROLIMUS | 1 | Oral | 1.5 MG, QD | 363.931 | MG | U | 21560 | 1.5 | MG | QD | ||||
| 114674456 | 11467445 | 8 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Oral | 1440 MG, QD | 0 | 1440 | MG | QD | |||||||
| 114674456 | 11467445 | 9 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114674456 | 11467445 | 1 | Liver transplant |
| 114674456 | 11467445 | 2 | Prophylaxis against transplant rejection |
| 114674456 | 11467445 | 3 | Immunosuppression |
| 114674456 | 11467445 | 8 | Liver transplant |
| 114674456 | 11467445 | 9 | Immunosuppressant drug therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114674456 | 11467445 | OT |
| 114674456 | 11467445 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114674456 | 11467445 | Cell death | |
| 114674456 | 11467445 | Cholestasis | |
| 114674456 | 11467445 | Hypercholesterolaemia | |
| 114674456 | 11467445 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114674456 | 11467445 | 1 | 20131108 | 20140109 | 0 | |
| 114674456 | 11467445 | 2 | 20140110 | 20140213 | 0 | |
| 114674456 | 11467445 | 3 | 20140214 | 20140904 | 0 | |
| 114674456 | 11467445 | 4 | 20140905 | 20141013 | 0 | |
| 114674456 | 11467445 | 5 | 20141014 | 20150414 | 0 | |
| 114674456 | 11467445 | 6 | 20150415 | 20150908 | 0 | |
| 114674456 | 11467445 | 7 | 20150909 | 0 | ||
| 114674456 | 11467445 | 8 | 20130718 | 0 |